Single-use bioprocessing system is majorly used in the upstream and downstream bioprocessing method. Moreover, key advantages offered by single-use bioprocessing such as cost reduction, increased productivity, low energy and water consumption during bioprocessing, easy disposable and reduced risk of cross contamination allows its easy and increased adoption over conventional bioprocessing systems. Moreover, government regulatory organizations are majorly adopting single-use bioprocessing systems, owing to its advantges. For instance, Australian Government: Therapeutic Goods Administration (TGA) allows the use of single-use systems in buffer preparation, mixing, and other upstream processing. Apart from this, TGA also proposed GMP regulation for filters, equipment used in single-use systems. Furthermore, increasing demand of biopharmaceuticals, growing investment on research and development activities and increasing number of key players offering affordable and technologically advanced disposable bioprocessing products are projected to drive growth of the single-use bioprocessing systems market over the forecast period.

Request for Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1754

Market Dynamics

The global single-use bioprocessing systems market is projected to witness significant growth over the forecast period, owing to its wide applications in production of monoclonal antibodies, vaccine production, and therapeutic drugs. Moreover, key players in the market are engaged in organic and in-organic growth strategies such as collaborations, strategic agreement, partnerships, mergers and acquisitions to retain competitive position in market. For instance, in April 2018, Saint-Gobain acquired the pharmaceutical business of Micro Hydraulics to strengthen its high performance material portfolio with the addition of single-use fluid handling components and systems. In August 2016, Saint-Gobain acquired Twin Bay Medical, which has added flexible tube retainers and single-use component portfolio of Twin Bay Medical into Saint-Gobain’s portfolio. In February 2015, Thermo Fisher Scientific acquired Advanced Scientifics, Inc., the provider of single-use technologies for customized bioprocessing solutions for deal value of US$ 300 million in cash. Furthermore, in November 2017, General Electric Company acquired Puridify, a bioprocessing start-up company. These acquisition help to add a nanofiber-based platform purification technology to GE Healthcare’s product portfolio. These mergers and acquisitions are expected to bring innovative single use bioprocessing systems during the forecast period.

Ask for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/1754

Key features of the study:

This report provides in-depth analysis of the single-use bioprocessing systems market and its market size (US$ Million) and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global single-use bioprocessing systems market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies

Key companies covered as a part of this study include Compagnie de Saint-Gobain S.A., Thermo Fisher Scientific Inc., Applikon Biotechnology BV, Parker-Hannifin Corporation, Sartorius AG, Eppendorf AG, Danaher Corporation, Merck KGaA, and General Electric Company.

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.

The global single-use bioprocessing systems market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for single-use bioprocessing systems market, research and consulting firms, new entrants and financial analysts.

Detailed Segmentation:

Global Single-use Bioprocessing Systems Market, By Product Type:

Instruments

Accessories

Global Single-use Bioprocessing Systems Market, By Application:

Monoclonal Antibody Production

Vaccine Production

Patient Specific Cell Therapies

Other Applications

Global Single-use Bioprocessing Systems Market, By End User:

Biotechnology and Pharmaceutical Companies

Research & Academic Research Institutes

Contract Research Organizations(CRO) & Contract Manufacturing Organizations(CMO)

Global Single-use Bioprocessing Systems Market, By Region:

North America Single-use Bioprocessing Systems Market

By Country:

U.S.

Canada

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]